Normal Vaginal Delivery in India and UAE | Complete Patient Guide

• IDEAL CANDIDATES FOR PLANNED NVD:

• Singleton pregnancy in vertex (cephalic) presentation confirmed by third-trimester ultrasound

• Gestational age ≥ 37 completed weeks (term pregnancy)

• Estimated fetal weight 2.5–4.0 kg by biometric ultrasound (BPD, HC, AC, FL parameters)

• Adequate maternal pelvis: clinical pelvimetry or MRI pelvimetry if borderline (diagonal conjugate > 11.5 cm, obstetric conjugate > 10 cm, interspinous diameter > 10 cm)

• Reassuring fetal wellbeing: reactive non-stress test (NST), biophysical profile (BPP) score ≥ 8/10, normal Doppler velocimetry (umbilical artery S/D ratio within gestational age norms)

• No placenta previa or low-lying placenta (placental edge ≥ 20 mm from internal os on transvaginal ultrasound)

• No active maternal herpes simplex virus (HSV) genital lesion

• No prior classical uterine incision (low transverse LSCS scar may be eligible for VBAC — trial of labour after cesarean — with appropriate risk counselling)

• REQUIRED PRE-ADMISSION INVESTIGATIONS:

• Complete blood count (CBC) with platelet count

• Blood group, Rh typing, and crossmatch

• Coagulation profile (PT, aPTT, fibrinogen) — especially if hypertensive disorder suspected

• Random blood glucose and HbA1c (gestational diabetes screening)

• Liver function tests and renal function tests

• Antenatal serological screen: VDRL, HIV, HBsAg, HCV antibody

• Third-trimester anomaly scan and placental localisation ultrasound (28–34 weeks)

• Group B Streptococcus (GBS) vaginal-rectal swab (35–37 weeks) — intrapartum antibiotic prophylaxis (penicillin G) if positive

• Cardiotocography (CTG) baseline trace on admission

• Urine routine and culture (to exclude asymptomatic bacteriuria)

• CONTRAINDICATIONS TO PLANNED NVD (REQUIRES CESAREAN SECTION):

• Placenta previa major (complete or partial)

• Vasa previa

• Transverse or oblique fetal lie persisting at term

• Footling breech presentation (external cephalic version — ECV — may be offered at 36–37 weeks to convert breech to vertex)

• Suspected cephalopelvic disproportion (CPD) confirmed on imaging

• Active primary genital herpes at onset of labour

• Prior classical (vertical) uterine incision or two or more prior LSCS

• Severe fetal compromise on Doppler (absent or reversed end-diastolic flow)

• Cord prolapse with non-vertex presentation

STANDARD NVD — SPONTANEOUS LABOUR: The majority of term pregnancies progress to spontaneous onset of labour (SOL), defined as regular painful uterine contractions producing progressive cervical change. Intrapartum management at accredited facilities includes: — Continuous electronic fetal monitoring (EFM/CTG) with STAN (ST waveform analysis) technology at leading centres, enabling fetal ECG-derived ST changes to be integrated with CTG interpretation, reducing false-positive operative delivery rates by 20–30% compared to CTG alone. — Pain management: Epidural analgesia (combined spinal-epidural, CSE, or low-dose epidural infusion using bupivacaine 0.0625–0.1% with fentanyl 2 mcg/mL) is offered at all major accredited hospitals. Nitrous oxide (Entonox 50:50) and IV opioid analgesia (remifentanil patient-controlled analgesia — remifentanil PCA — being increasingly available at tertiary centres) are alternatives. — Amniotomy (artificial rupture of membranes, ARM) combined with oxytocin augmentation if labour is progressing suboptimally (cervical dilation rate < 0.5 cm/hour in active phase per NICE guidelines). — Foetal scalp blood sampling (FBS) for lactate or pH measurement when CTG is non-reassuring (scalp lactate ≥ 4.8 mmol/L or pH < 7.20 mandates immediate delivery).

LABOUR INDUCTION: For post-dates pregnancies (≥ 41+0 weeks) or medical indications (hypertensive disorders, gestational diabetes, IUGR), labour is induced using: — Cervical ripening: Dinoprostone (PGE2) vaginal gel or controlled-release pessary (Propess 10 mg, releasing 0.3 mg/hour over 24 hours), or Misoprostol (PGE1) 25–50 mcg vaginally/orally every 4–6 hours per FIGO protocols. — Mechanical methods: Balloon catheter (Foley or double-balloon Cook catheter) inserted intracervically — preferred in patients with prior uterine surgery to minimise uterine hyperstimulation risk. — Oxytocin infusion: Low-dose protocol (0.5–2 mU/min, titrated upward every 15–30 minutes to a maximum of 20–40 mU/min) following membrane rupture.

OPERATIVE VAGINAL DELIVERY (OVD): When the second stage is prolonged (> 3 hours with epidural, > 2 hours without in nulliparous women; > 2 hours with epidural, > 1 hour without in multiparous women) or fetal compromise occurs at near-complete descent, operative vaginal delivery is performed: — Vacuum extraction (Ventouse): Kiwi OmniCup or Silc-cup applied to the fetal head at the flexion point; maximum 3 pulls over 15–20 minutes. Preferred when the fetal head is at +2 station or below. — Forceps delivery: Neville-Barnes or Wrigley's forceps used by skilled obstetricians, particularly for rotational deliveries (Kjelland's forceps for mid-cavity rotation) or when precise head control is required (e.g., preterm delivery). — OVD success rates: 85–95% for outlet OVD; 70–85% for low-cavity procedures at specialist centres.

VBAC (VAGINAL BIRTH AFTER CESAREAN): Patients with a single prior lower-segment cesarean section (LSCS) may be offered a trial of labour (TOL/VBAC) if: prior incision was transverse, no recurrent indication, no macrosomia, and continuous intrapartum monitoring is available. VBAC success rates are 60–80% at high-volume obstetric centres with 24-hour surgical cover. Uterine rupture risk is 0.5–0.9% with TOL vs. 0.02% with elective repeat CS — patients are counselled using validated VBAC calculators (MFMU Network VBAC Calculator, Grobman model).

WATER BIRTH AND ALTERNATIVE BIRTH SETTINGS: A growing number of JCI-accredited hospitals in Dubai (Mediclinic City Hospital, Aster Hospital) and India (Cloudnine Group, Apollo Cradle) offer hydrotherapy pools for first-stage labour and supervised water birth in the second stage for low-risk pregnancies, consistent with RCOG and Cochrane evidence showing reduced analgesia requirements and similar neonatal outcomes compared to conventional delivery.

PHASE 1 — PRE-TRAVEL & ANTENATAL ASSESSMENT (Weeks 34–36 of Pregnancy): — GAF Healthcare care coordinator reviews the patient's antenatal records, ultrasound reports, and blood work to determine clinical eligibility for NVD at the chosen destination. — A teleconsultation is arranged with the receiving obstetrician (Maternal-Fetal Medicine specialist or Consultant Obstetrician-Gynaecologist) for personalised birth planning. — Birth plan documentation: analgesia preferences, support person policy, episiotomy preferences, third stage management, skin-to-skin and delayed cord clamping preferences. — Travel is generally safe by air up to 36 weeks of gestation (most airlines require a physician letter after 28 weeks and refuse boarding after 36–37 weeks); patients are advised to arrive at the destination by 36–37 weeks. — Pre-arrival checklist: comprehensive antenatal records, vaccination certificates, travel insurance with maternity and neonatal cover, and GAF Healthcare's dedicated obstetric case file.

PHASE 2 — ADMISSION AND EARLY LABOUR (Day 0): — Hospital admission occurs when contractions are regular and cervix is ≥ 3–4 cm dilated (active labour) or membranes have ruptured (PROM). — Admission baseline: CTG (minimum 20 minutes), vaginal examination, IV access, blood group confirmation, and anaesthetic review if epidural is desired. — Epidural catheter is sited by an obstetric anaesthetist typically when cervical dilation reaches 4–5 cm (or earlier on patient request, as per ACOG guidance — early epidural does not increase CS rates). — Labour progress is documented on a WHO-recommended partograph: cervical dilation plotted against time, fetal head descent, contraction frequency and duration, maternal vitals, and fetal heart rate patterns.

PHASE 3 — ACTIVE LABOUR AND DELIVERY (Hours 4–12, Variable): — Active phase: cervical dilation progresses at ≥ 0.5–1 cm/hour. Augmentation with oxytocin infusion is initiated if progress is inadequate. — Second stage: mother is guided through passive descent (rest for 1 hour if epidural in situ) followed by active pushing. Upright or lateral positions are encouraged to utilise gravity and reduce perineal trauma. — Delivery of the fetal head using controlled, slow-delivery technique (McCandlish technique or hands-poised approach per HOOP trial evidence) to minimise third- and fourth-degree perineal tears. — Immediate newborn care: Apgar scoring at 1 and 5 minutes, delayed cord clamping (minimum 60 seconds as per WHO/ACOG guidelines to improve neonatal iron stores), skin-to-skin contact initiated within 1 minute of birth. — Third stage: oxytocin 10 IU IM administered, controlled cord traction (Brandt-Andrews manoeuvre) for placental delivery. Blood loss is quantified (cumulative weighed blood loss method preferred over visual estimation).

PHASE 4 — IMMEDIATE POSTPARTUM (Hours 0–24): — Fourth stage monitoring: uterine tone, lochia, blood pressure, and perineal status assessed every 15 minutes for 1 hour, then hourly for 4 hours. — Perineal repair (if episiotomy or tear): under local or regional anaesthesia, using absorbable synthetic sutures (Vicryl Rapide 2-0/3-0) with continuous subcuticular technique for skin closure. — Breastfeeding initiation within the first hour of birth; lactation consultant support available at all accredited facilities. — Neonatology review: newborn examination, Vitamin K prophylaxis (phytomenadione 1 mg IM), hepatitis B vaccine within 24 hours, and BCG at accredited Indian hospitals. — Haemoglobin recheck at 6–12 hours postpartum if blood loss > 500 mL.

PHASE 5 — POSTNATAL WARD STAY (Days 1–2): — Ambulation encouraged within 2–4 hours of delivery (reduces VTE risk and promotes uterine involution). — Bladder care: urinary catheter (if inserted for epidural analgesia) removed within 12–16 hours; voiding trial documented. — Analgesia: paracetamol 1 g every 6 hours + ibuprofen 400 mg every 8 hours (avoiding in breastfeeding complications) for perineal pain; ice packs and topical anaesthetic gel for perineal wound. — Thromboprophylaxis: TED stockings for all patients; LMWH (enoxaparin 40 mg SC once daily) for patients with BMI > 30, prior VTE, or prolonged labour per RCOG Green-top guideline. — Discharge criteria: stable maternal vitals, adequate urine output, satisfactory breastfeeding established or formula plan in place, normal neonatal examination and feeding, and perineal wound comfortable.

PHASE 6 — POST-DISCHARGE AND RECOVERY (Weeks 1–6): — Week 1: Rest, perineal hygiene (saline soaks, peri-bottle), lochia monitoring (normal: rubra for 3–4 days, then serosa, then alba up to 6 weeks). Avoid heavy lifting (> 5 kg) and sexual intercourse until 6-week postnatal review. — Week 2: Most mothers of uncomplicated NVD are mobile and capable of light daily activities. GAF Healthcare arranges a postnatal teleconsultation with the delivering obstetrician. — Weeks 4–6: Postnatal check (uterine involution, cervical smear discussion, contraception counselling, pelvic floor physiotherapy referral if perineal trauma occurred). Fit-to-fly medical clearance issued by the obstetrician and neonatologist for both mother and baby.